Novel MRPL13-ALK and PPP1CB-ALK Double Fusion As a Potential Mechanism of Acquired Resistance to First-Line Osimertinib in EGFR-Mutant High-Grade Neuroendocrine Tumor of the Lung

Detalles Bibliográficos
Autores principales: Jiao, Yuyan, Liu, Ming, Luo, Ningning, Guo, Hao, Li, Jianzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474472/
https://www.ncbi.nlm.nih.gov/pubmed/34589958
http://dx.doi.org/10.1016/j.jtocrr.2020.100079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474472/
https://www.ncbi.nlm.nih.gov/pubmed/34589958
http://dx.doi.org/10.1016/j.jtocrr.2020.100079

Ejemplares similares